28 September 2023

VIVEbiotech: A Lentiviral Vector Specialist Bridging the Gap Between R&D and Commercialisation

An article featured by Natalia Elizalde, Chief Business Development Officer at VIVEbiotech, has just been published by European Pharmaceutical Manufacturer.

Read more

14 September 2023

The Medicine Maker publishes an opinion article after interviewing Natalia Elizalde

The Medicine Maker has published an opinion article after interviewing Natalia Elizalde, VIVEbiotech´s Chief Business Development Officer.

Read more

24 August 2023

VIVEbiotech will lead a session with speakers from top international companies during upcoming Biospain

Biospain is a biotechnology congress organized by AseBio - Asociación Española de Empresas Biotecnológicas and is held every two years in a...

Read more

14 August 2023

Contribution to an article defining the benefits of lentiviruses in BioPharm International

In a recent article in BioPharm International, Chris Spivey speaks about different types of viral vectors that are regularly used in gene therapy, each with...

Read more

17 July 2023

VIVEbiotech participates in the XVI Annual Biotechnology Congress

Soledad Baños-Mateos, senior researcher of the Department of Technological Innovation of VIVEbiotech, has participated in the XVI Congreso Anual de Biotecnología (BAC Badajoz 2023)...

Read more

11 July 2023

VIVEbiotech contributes to accelerate the development of muscular dystrophies through the European MAGIC project

VIVEbiotech is a CDMO GMP that develops and manufactures lentiviral vectors from early stage to commercial scale. It is currently working on more than 40 international...

Read more

19 June 2023

VIVEbiotech interview on C&GT manufacturing trends at Drug Discovery World

VIVEbiotech participated in the ISCT, International Society for Cell & Gene Therapy´s (ISCT) Annual Meeting took place three weeks ago in beautiful Paris.

Read more

13 June 2023

Gurutz Linazasoro, CEO of VIVEbiotech, participates in the Foro de Biociencia

Gurutz Linazasoro, CEO of VIVEbiotech, will participate tomorrow in a round table discussion entitled "Boosting science and research of high quality and impact" at the...

Read more

4 June 2023

VIVEbiotech has successfully participated in 5 international congresses in the first half of the year

VIVEbiotech has successfully participated in 5 international congresses in the first half of the year.

Read more

18 May 2023

Article in RegMedNet about lentiviral vectors development and manufacturing challenges

Natalia Elizalde was interviewed at the Phacilitate's Advanced Therapies Week that took place in Miami in January this year.

Read more